Does Rallies show Form 4 insider transactions for CVSA?

Yes. Rallies tracks CVSA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CVSA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CVSA. It does not provide personalized investment advice.

CVSA (Covista Inc.) Stock Analysis - Insider Trades

Covista Inc. (CVSA) is a publicly traded the market company. As of May 21, 2026, CVSA trades at $126.01 with a market cap of $4.35B and a P/E ratio of 0.00. CVSA moved -0.08% today. Year to date, CVSA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $94.11 to $133.74. Analyst consensus is strong buy with an average price target of $156.25. Rallies surfaces CVSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CVSA stock inside the company?

Recent CVSA insider activity includes Phelan Robert J. sold 10.00K, BECK DOUGLAS G. sold 9.62K, Cox Karen Sue sold 2.00K, Beard, Stephen W. sold 15.87K, and MALAFRONTE MICHAEL W bought 8.89K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CVSA Key Metrics

Key financial metrics for CVSA
Metric	Value
Price	$126.01
Market Cap	$4.35B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$133.74
52-Week Low	$94.11
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Recent CVSA Insider Trades

Phelan Robert J. sold 10.00K (~$1.26M) on May 8, 2026.
BECK DOUGLAS G. sold 9.62K (~$1.22M) on May 8, 2026.
Cox Karen Sue sold 2.00K (~$249.00K) on May 8, 2026.
Beard, Stephen W. sold 15.87K (~$2.08M) on May 8, 2026.
MALAFRONTE MICHAEL W bought 8.89K (~$897.34K) on Mar 11, 2026.

Latest CVSA News

Covista Unveils Canvas-Integrated AI Classroom, Sees 3,400 Enrollments in First Week — Apr 14, 2026
Covista Names Michael Betz Chief Growth & Innovation Officer with Marketing Oversight — Apr 6, 2026
Covista Unveils Three-Year Growth Roadmap, Forecasts $1.9B–$1.94B 2026 Revenue — Feb 27, 2026
Covista Rebrands, Holds Investor Day and Sees 1.97% Share Surge — Feb 24, 2026

CVSA Analyst Consensus

4 analysts cover CVSA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $156.25.

Common questions about CVSA

Who is trading CVSA stock inside the company?: Recent CVSA insider activity includes Phelan Robert J. sold 10.00K, BECK DOUGLAS G. sold 9.62K, Cox Karen Sue sold 2.00K, Beard, Stephen W. sold 15.87K, and MALAFRONTE MICHAEL W bought 8.89K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CVSA?: Yes. Rallies tracks CVSA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CVSA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CVSA. It does not provide personalized investment advice.